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Abstract
Chronic widespread pain (CWP) is common in the general population. It is unclear how people reporting this problem present in
primary care; they may regularly consult for regional pains without being recognized as having a generalized condition. Our
objectives were to determine the prevalence of people consulting in primary care for musculoskeletal conditions in different body
regions on different occasions (recurrent regional pain consultation), the proportion with diagnosed generalized pain and survey-
reported widespread pain, and if they have features characteristic of CWP. Phase 1 used electronic records from 12 general
practices in North Staffordshire (Consultations in Primary Care Archive) from 2005 to 2009. Phase 2 used linked self-reported health
and primary health care data from 8286 people aged .50 years in 8 general practices (North Staffordshire Osteoarthritis Project)
between 2002 and 2005. In Phase 1, 11% of registered patients fulfilled criteria for recurrent regional pain consultation. Three-
quarters had no recorded CWP-related generalized pain condition (eg, fibromyalgia). In Phase 2, 53% of recurrent regional pain
consulters had survey-reported widespread pain and 88% had consulted for somatic symptoms. Self-reported general health was
worse in recurrent regional pain consulters than in single-region consulters and poorest in those who also reported persistent
widespread pain. Recurrent regional pain consulters are a heterogeneous group of frequent consulters sharing features with CWP
(eg, somatic symptoms) but including those less severely affected. They lie on the spectrum of polysymptomatic distress
characteristic of CWP and represent a group whose needs may be better met by earlier diagnosis of multisite pain.
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1. Introduction
Chronic widespread pain (CWP) is characterized by long-lasting
pain inmultiple body regions and is associatedwith other physical
symptoms such as fatigue, concentration problems, and
psychologic distress. CWP is common, with an estimated general
population point prevalence of 10%.26
In the American College of Rheumatology 1990 (ACR-1990)
definition,42 CWP is the fundamental feature of fibromyalgia,
defined as pain lasting $3 months, located axially, above and
below the waist, and on both sides of the body. The updated
definition (ACR-2010)41 emphasizes additional physical
symptoms (eg, fatigue, waking unrefreshed) associated with
fibromyalgia and placed fibromyalgia at one extreme on
a spectrum of polysymptomatic distress that includes CWP.
Because of the range of symptoms experienced and a multidis-
ciplinary approach to treatment, it has been argued that
fibromyalgia and CWP should be managed in primary
care.9,11,12,32,34 However, general practitioners (GPs) may not
recognize fibromyalgia as a valid diagnosis,1,6,22,23 may receive
inadequate formal training in fibromyalgia,1,7,22 and may have
limited awareness of diagnostic criteria.6,7,22Most UKprimary care
uses Read codes to summarize patient encounters within
electronic records.3,35 There is no Read code for CWP, although
the syndrome will be included in the forthcoming International
Classification of Diseases, 11th edition.8However, although a code
does exist for fibromyalgia, the disparity between its estimated
community andprimary care prevalences suggests that the label of
fibromyalgia is not often used in general practice.10,16 This may
reflect the controversial nature of fibromyalgia and CWP, or
concern about the wider implications of labeling.2 Patients fulfilling
CWPcriteriamay instead be diagnosed and treated in primary care
for individual regional pains (eg, knee pain), rather than for
a generalized pain condition.33
Electronic health records (EHRs) present opportunities to
study health care in large cohorts with many years of follow-up.
However, using EHR data relies on the definition of robust
clinical phenotypes.14 Rohrbeck et al.33 mapped the ACR-1990
CWP criteria to primary care consultation patterns for regional
musculoskeletal complaints based on a select number of
regional musculoskeletal pain Read codes in one general
practice (Box 1). Patients identified using this recurrent regional
pain consulter definition consulted for more health problems
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and reported worse self-reported general health, more sleep
problems, and higher levels of fatigue than controls and were
concluded to be potentially unrecognized as having a more
generalized condition. If GPs do treat the condition presented at
each consultation as a regional problem only, then early
opportunities for interventions aimed at generalized pain may
be missed and long-term disability exacerbated by incomplete
management. A consultation-based CWP definition may
prompt earlier identification of patients and more timely
management. It would also allow estimates of CWP prevalence,
health surveillance, and monitoring of trends over time.
Building on earlier work,33 our objectives were to (1) determine
the prevalence of recurrent regional pain consultation in primary
care; (2) assess the extent to which such patients may be
underrecognized as having widespread pain; and (3) determine
whether they share features characteristic of CWP.
2. Methods
The study consisted of 2 phases. In Phase 1, we used routinely
recorded primary care data to investigate prevalence of recurrent
consultation for regional pain conditions and determined the
overlap with recorded nonspecific generalized pain that may be
related to fibromyalgia, to assess the extent to which widespread
pain may be unrecognized in UK primary care. In Phase 2, we
used linked survey and primary care consultation data to
investigate whether patients with recurrent regional pain consul-
tation have survey-reported CWP and have similar characteristics
to those self-reporting CWP.
2.1. Phase 1
We used anonymized routinely collected primary care data from
general practices contributing to the Consultations in Primary
Care Archive (CiPCA) in North Staffordshire, United Kingdom.
The North Staffordshire Research Ethics Committee gave ethical
approval for the use of the CiPCA database for research
(reference 03/04). In the United Kingdom, 98% of the population
is registeredwith a National Health Service (NHS) GP,15 access to
care is free, and GPs act as the entry point to all routine health
care. Although North Staffordshire is more deprived than the
average for England, the practices cover both affluent and
deprived areas. Routine clinical data recorded by the practices
are regularly audited.30 Prevalence of musculoskeletal conditions
in CiPCA has been demonstrated to be similar to that of larger
national primary care consultation databases17 and international
databases.19We included the 12CiPCApractices for which there
were complete data for the years 2005 to 2009, with a de-
nominator population base of 79,796 people registered (all ages,
with full registration for the 5-year study period).
We used the Read-coded consultation data for this 5-year
period to identify: (1) patients fulfilling the original recurrent
regional pain consultation algorithm (Box 1) based on a published
list of all regional musculoskeletal morbidity codes (n 5 4482)20;
and (2) individuals recorded with nonspecific (ie, with no clear
established underlying diagnosis) generalized pain conditions
related to CWP. These included fibromyalgia, fibrositis, rheuma-
tism, myalgia, arthralgia, and polyalgia. The code lists are
available from www.keele.ac.uk/mrr. We excluded patients
without complete registration; that is, those who were not
registered with the same primary care practice for the full
5-year period from 2005 to 2009.
2.1.1. Analysis
We calculated the 5-year recorded prevalence of recurrent
regional pain consultation, fibromyalgia, and nonspecific gener-
alized pain and the total prevalence of recurrent regional pain
consultation or generalized pain combined. We also recalculated
total prevalence (of recurrent regional pain consultation or
nonspecific generalized pain combined) after excluding those
with specific generalized musculoskeletal diagnoses (ie, rheu-
matoid arthritis, systemic lupus erythematosus, polymyalgia
rheumatica, ankylosing spondylitis, Sjo¨gren’s syndrome, and
hypothyroidism) during the 5-year period. The denominator
population was patients registered with the CiPCA practices
between 2005 and 2009. We directly standardized prevalence
figures using the UK general population age and sex distribution
for 2009 provided by the Office for National Statistics.28
We then calculated the percentage of recurrent regional pain
consulters recorded as also consulting for a nonspecific gener-
alized pain complaint and the percentage of nonspecific pain
consulters who were also recurrent regional pain consulters.
2.2. Phase 2
The Phase 2 study population was drawn from the North
Staffordshire Osteoarthritis Project (NorStOP), a prospective study
of pain and general health of all community-dwelling adults aged 50
years and over registered with 8 general practices.37 The North
Staffordshire and Hereford and Worcester Research Ethics
Committees granted ethical approval for the NorStOP project. We
included those who had responded to both baseline and 3-year
postal health surveys from the 3 identically recruited and measured
cohorts (NorStOP 1: 2002, NorStOP 2: 2003, NorStOP 3: 2004,
2005),hadconsented tomedical record review,andhadaminimum
of 5 years of medical record data available. Questionnaires were
mailed with a letter from the GP practice, accompanied by a study
information leaflet, and reminders were sent to nonresponders after
2 and 4 weeks. GPs checkedmailing lists before mailing to exclude
unsuitable patients (eg, patientswith terminal illnesses or dementia).
Full details of the study protocol and data collection have been
published previously.37
2.2.1. Pain status
We established consultation-based pain status using linked
primary care medical record data for the 5-year period starting 2
years before the baseline health questionnaire. We identified
those fulfilling the recurrent regional pain consultation algorithm
and those consulting for musculoskeletal problems in a single
region (recorded as consulting in just one of the 3 defined body
regions—axial, upper limb, or lower limb—during the 5-year
study period).
Self-reported pain status was collected by postal questionnaire
at baseline and 3-year follow-up. A self-completed body manikin
was used to establish the location of body pain lasting for$1 day
Box 1.The recurrent regional pain consulter definition.33
In a period of 5 consecutive years, a patient fulfils all of 1-4:
1. At least 1 consultation for a musculoskeletal complaint in the axial skeleton
(neck and back);
2. At least 1 consultation for an upper- or lower-limb complaint;
3. At least 1 consultation for a regional musculoskeletal complaint in each of
3 separate years;
4. At least 4 consultations for regional musculoskeletal complaints during the
5-year period.
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in the past 4weeks. Pain diagrams have been demonstrated to be
a reliable means of classifying widespread pain based on existing
criteria.24 ACR-1990 widespread pain was defined as axial pain,
pain in the left and right sides of the body, and pain above and
below the waist.42 Because of the limitations of the self-reported
data, we were unable to ascertain chronicity using the ACR-1990
definition of $3 months duration. Widespread pain reported at
both baseline and 3 years was therefore used as a marker of
“persistent” widespread pain. Self-reported widespread pain was
classified into 2 categories as: (1) ACR-1990 widespread pain at
baselineor3 years; and (2) ACR-1990widespreadpain at baseline
and 3 years (persistent widespread pain).
2.2.2. General health measures
Consultation-based measures were collected from medical
records over the 5-year period. These were somatic symptom
count, frequent attendance, and musculoskeletal and non-
musculoskeletal consultation counts.
CWP is often associated with additional symptoms such as
fatigue and concentration problems. The ACR-2010 fibromyalgia
definition41 emphasizes the importance of these somatic
symptoms by including them in the fibromyalgia case definition.
We identified the number of somatic symptoms (eg, fatigue,
insomnia, and nausea) recorded for each patient over the 5-year
study period. We used the symptoms itemized in the ACR-2010
fibromyalgia criteria to identify corresponding Read codes.
CWPpatients have been found to consult more frequently than
patients with no pain, independent of their level of psychological
distress,21 suggesting that frequent attendance is a feature of
CWP. Research has demonstrated an association between CWP
and help-seeking behavior for health problems.13 We defined
frequent attender status as being in the top 10% of consulters for
nonmusculoskeletal problems over the 5-year period. Frequent
attendance defined in this way is also an indirect measure of
comorbidity. Nonmusculoskeletal consultations were defined as
primary care contacts recorded with any Read code (including
numeric chapters 0-9: history, examination, procedural and
administrative codes, and chapters A-Z: diagnostic codes)
except the musculoskeletal codes.20
We collected self-reported health status from baseline health
questionnaire responses. General health was assessed using the
12-item short form health survey (SF-12) physical health compo-
nent summary score.39 Psychological health was assessed using
the anxiety and depression scores of the Hospital Anxiety and
Depression Scale (HADS).43 Cognitive impairment was measured
using the alertness subscale of the Sickness Impact Profile (SIP).5
Sleep was assessed by 4 questions, in which respondents were
asked if they had the following sleep problems on most nights: (1)
trouble falling asleep; (2) waking at night; (3) trouble staying asleep;
and (4) waking up tired. A positive response to any of the 4 sleep
questions was used to indicate a reported sleep problem.
2.2.3. Analysis
We descriptively compared recurrent regional pain consulters,
thosewho consulted for pain in a single region (axial, upper limb, or
lower limb), and all respondents with self-reported persistent
widespread pain by age, sex, consultation-based health meas-
ures, and self-reported health measures. We then determined the
positive predictive values of the recurrent regional pain consultation
definition for each of the self-reported widespread pain definitions.
For the main analysis, we compared different patterns of pain
consultation with self-reported persistent widespread pain status
(defined as having ACR-1990 widespread pain at both baseline
and 3 years), by consultation-based health measures and self-
reported health measures. Specifically, we compared the
following 4 mutually exclusive groups of patients: (1) recurrent
regional pain consulters who also reported persistent widespread
pain; (2) recurrent regional pain consulters who did not report
persistent widespread pain (but may have reported widespread
pain on either the baseline or the 3-year survey); (3) respondents
reporting persistent widespread pain but not meeting the
recurrent regional pain consulter definition; and (4) single-region
consulters not reporting persistent widespread pain. For this
analysis, single-region consulters not reporting persistent wide-
spread pain were the control (reference) group.
We compared these 4 groups on frequent attendance,
recording of$1 somatic symptoms, reporting$1 sleep problems
on most nights, SF-12 physical component summary score, SIP
cognitive impairment score, and HADS anxiety and depression
scores, using logistic or linear regression as appropriate, and
adjusting for age and sex.
3. Results
3.1. Phase 1
The 5-year denominator (all ages) in CiPCA was 79,796. Nine
thousand one hundred seventy-two patients fulfilled the recurrent
regional pain consultation criteria and 6466 patients were
recorded with nonspecific generalized pain conditions.
3.1.1. Prevalence
Standardized 5-year consultation prevalence ranged from 0.36%
(95% confidence interval [CI]: 0.32%-0.40%) for recorded
fibromyalgia to 14.61% (95% CI: 14.36%-14.86%) for the
combined prevalence of recurrent regional pain consultation or
a code recorded for a nonspecific generalized pain condition
(Table 1). Five-year prevalence of recurrent regional pain
consultation was 9.87% (95% CI: 9.66%-10.07%). The age and
sex distribution of recurrent regional pain consultation was similar
to those of nonspecific generalized pain conditions, except that
prevalence dipped slightly for nonspecific generalized pain
consultation in the highest age band but continued to increase
for recurrent regional pain consultation (Fig. 1).
3.1.2. Overlap of recurrent regional pain consultation with
nonspecific generalized pain
Of the 6466 patients with a record of a nonspecific generalized
pain condition, 290 (4%) were recorded with a specific fibro-
myalgia code. Thirty-three percent (2106/6466) of nonspecific
generalized consulters also fulfilled the recurrent regional pain
consulter definition. The recurrent regional pain consultation
algorithm identified 42% (123/290) of those recorded with
fibromyalgia codes. Twenty-three percent (2106/9172) of re-
current regional pain consulters had a recorded nonspecific
generalized pain condition.
3.2. Phase 2
Of 26,129 eligible participants at baseline, 71% (n 5 18,497)
responded to the baseline health survey questionnaire. Of those
consenting to follow-up and still registered with the GP (n 5
11,900), 81% (n 5 9665) responded to the 3-year follow-up
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questionnaire. Of the 9665 people responding to both thebaseline
and the 3-year questionnaires, 9% (n 5 831) did not consent to
medical record review and 6% (n5 548) had,5 years of medical
record data available, leaving 8286 participants eligible for
inclusion in this study (Supplementary Figure S1, available online
at http://links.lww.com/PAIN/A352).
Incomplete responders (either baseline-only responders or
baseline and 3-year responders without 5 years of medical record
data) showed generally small differences from the study population
on all baseline variables assessed (Supplementary Table S1,
available online at http://links.lww.com/PAIN/A352). Nonrespond-
ers at baseline were slightly older (mean difference 5 0.86 years,
95% CI: 0.53-1.18) and more likely to be male (nonresponders:
49% male; study population: 46% male, percentage difference:
3.15%, 95% CI: 1.59%-4.71%) than the study population.
Of the 8286 individuals in the study population, 85% (n5 7076)
self-reported musculoskeletal pain at either baseline or 3 years.
Two thousand, eight hundred three (35%) reported ACR-1990
widespread pain on one or both surveys, of whom 1190 (14% of
all the study population) reported ACR-1990 widespread pain at
both baseline and 3 years (persistent widespread pain).
Eighty percent (6611/8286) of the study population had at least
one recorded musculoskeletal consultation in the 5-year period.
Twenty-two percent (n 5 1786) of the population were identified
as recurrent regional pain consulters, and 24% (n 5 1979)
consulted for amusculoskeletal problem in only one region during
the 5-year study period.
3.2.1. Patient characteristics
Descriptive statistics for participants with recurrent regional pain
consultation and/or self-reported persistent widespread pain are
presented in Table 2. Mean age was similar (64-65 years) across
pain definitions. Sixty-four percent of patients with self-reported
persistent widespread pain were female, which was similar to the
figure of 61% observed in recurrent regional pain consulters.
Eighty-eight percent (n 5 1567) of recurrent regional pain
consulters had at least one recorded consultation for a somatic
symptom, compared with 81% (n5 963) of those with persistent
widespread pain. In participants consulting for a single region,
48% were female, mean age was 64, and 62% (n 5 1111) self-
reported persistent widespread pain.
3.2.2. Agreement between consultation-based and self-
reported pain status
Table 3 shows the agreement between consultation-based pain
status and self-reported pain status. Virtually all recurrent regional
pain consulters (97%, n5 1727) had self-reported pain. Fifty-three
percent (942/1786) of recurrent regional pain consulters reported
Table 1
Phase 1: 5-year prevalence of recorded pain in those registered inCiPCApractices for the full 5-year period from 2005 to 2009 (all
ages).
Consultation-based pain definition n Five-year recorded prevalence, % (95% CI)
Crude Standardized*
Fibromyalgia 290 0.37 (0.33-0.42) 0.36 (0.32-0.40)
Nonspecific generalized pain 6644 8.10 (7.92-8.29) 6.91 (6.73-7.08)
Recurrent regional pain consultation 9172 11.49 (11.27-11.72) 9.87 (9.66-10.07)
Recurrent regional pain consultation and/or
nonspecific generalized pain
13,532 16.96 (16.70-17.22) 14.61 (14.36-14.86)
Recurrent regional pain consultation and/or
nonspecific generalized pain excluding specific
generalized musculoskeletal diagnoses†
12,364 15.49 (15.25-15.75) 13.44 (13.19-13.68)
* Directly standardized to UK general population figures for 2009 (source: Office for National Statistics).28
† Excludes any patients recorded with rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, ankylosing spondylitis, Sjo¨gren’s syndrome, or hypothyroidism.
CiPCA, Consultations in Primary Care Archive; CI, confidence interval.
Figure 1. Phase 1: age and sex distribution for the 5-year consultation prevalence of: (i) recorded fibromyalgia coding; (ii) recorded nonspecific generalized pain
coding; and (iii) recurrent regional pain consultation for all those fully registered with the CiPCA practices from 2005 to 2009. CiPCA, Consultations in Primary Care
Archive., Y-axis scale varies between (i) and (ii) and (iii).
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widespread pain on one or both surveys, whereas 25% (445/1786)
reported persistent widespread pain at both baseline and 3 years.
Patients recorded as consulting for single-region (axial, upper, or
lower limb) pain reported less widespread pain than recurrent
regional pain consulters—with 27% (532/1979) reporting wide-
spread pain on one or both surveys and 10% (194/1979) reporting
widespread pain at both baseline and 3 years. Recurrent regional
pain consulters represented 37% (445/1190) of those reporting
persistent widespread pain. However, individuals from the large
group who consulted with more than single-site musculoskeletal
pain but who did not meet the definition for recurrent regional pain
consultation (other musculoskeletal consultations) represented
40% (473/1190) of those reporting persistent widespread pain.
The single-region controls without self-reported persistent
widespread pain had the best consultation-based and self-
reported health. The 2 groups of recurrent regional pain
consulters had the most severe consultation-based health on
all measures, with those also reporting persistent widespread
pain having the worst consultation-based health (Table 4). For
example, the odds of being a frequent attender for non-
musculoskeletal conditions compared with the control group
(single-region consulters) were 7.07 (95% CI: 5.21-9.58) in
recurrent regional pain consulters with persistent widespread
pain; 4.99 (95% CI: 3.87-6.43) in recurrent regional pain
consulters without persistent widespread pain; and 2.55 (95%
CI: 1.86-3.48) in those with persistent widespread pain who were
not recurrent regional pain consulters.
Individuals both self-reporting persistent widespread pain and
identified as recurrent regional pain consulters were the most
severely affected on all self-reported health measures, followed
closely by those with persistent widespread pain but not fulfilling
the recurrent regional pain consultation definition. Those fulfilling
the recurrent regional pain consulter definition but not reporting
persistent widespread pain had poorer self-reported health than
the control group. For example, the odds of reporting a sleep
problem compared with the control group were 3.07 (95% CI:
2.47-3.81) in recurrent regional pain consulters with persistent
widespread pain; 2.97 (95% CI: 2.48-3.54) in those with
persistent widespread pain but not recurrent regional pain
consulters; and 1.42 (95% CI: 1.22-1.64) in recurrent regional
pain consulters without persistent widespread pain.
4. Discussion
The first phase of our study determined a prevalence of recurrent
regional pain consultation to primary care similar to estimates
Table 2
Phase 2: age, sex, consultation-based health, and self-reported health characteristics by single-region consulter, recurrent
regional pain consulter, and self-reported CWP status (ACR-1990 at baseline and 3 years), age ‡50 years.
Nonmutually exclusive groups
Consultation-based pain Self-reported persistent widespread pain
Single-region consulters Recurrent regional
pain consultation
ACR-1990 baseline and 3 years
Number 1979 1786 1190
Mean age (SD) 64 (9) 65 (9) 64 (9)
Female, number (%) 959 (48) 1084 (61) 758 (64)
Consultation-based health
Mean somatic symptom count (SD) 1.24 (1.41) 2.66 (2.10) 2.21 (1.99)
One or more recorded somatic symptoms (%) 1258 (64) 1567 (88) 963 (81)
Mean nonmusculoskeletal consultation
count (SD)
27 (20) 44 (27) 39 (25)
Mean musculoskeletal consultation
count (SD)
2 (2) 12 (8) 8 (9)
Frequent attenders (nonmusculoskeletal
consultations); number (%)
101 (5) 405 (23) 209 (18)
Self-reported mental and physical health*
Mean (SD) SF-12 physical component summary
(0 worst health–100 best health)†
44.5 (11.7) 36.8 (11.8) 31.7 (10.6)
Mean (SD) anxiety score (0 best health–21 worst
health)‡
6.1 (4.0) 7.5 (4.1) 8.5 (4.4)
Mean (SD) depression score (0 best health–21
worst health)‡
3.9 (3.3) 5.2 (3.5) 6.4 (3.8)
Mean (SD) cognitive impairment score
(0 best health–100 worst health)§
10.9 (19.9) 16.1 (22.8) 21.7 (25.8)
Number (%) reporting sleep problems on most
nights‖
683 (35) 818 (46) 710 (60)
* Data on these variables were incomplete with n ranging from 1550 to 1741 for recurrent regional pain consulters and from 1056 to 1178 for persistent widespread pain.
† Twelve-item short-form health survey–physical component summary39: high score 5 best health (scores are normalized to a general population mean of 50).
‡ Hospital Anxiety and Depression Scale43: high score 5 worst health.
§ Sickness Impact Profile—Alertness subscale5: high score 5 worst health.
‖ Percentages calculated based on n equal to participants providing valid responses only.
CWP, chronic widespread pain; SD, standard deviation.
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based on self-reported CWP in the general population.26 Three-
quarters of recurrent regional pain consulters did not have a code
recorded for generalized pain conditions related to CWP (eg,
fibromyalgia). They therefore had widespread pain potentially
unrecognized as such by their GP.
In the second phase, we established some overlap between
consultation-based and self-reported widespread pain, with half of
all recurrent regional pain consulters over a 5-year period self-
reporting widespread pain at least once. However, only one-quarter
reported persistent widespread pain during this period. Conversely,
only a minority of all those who self-reported CWP (37%) fulfilled the
recurrent regional consulter definition during the 5-year period.
There were similar patterns of poor health (eg, more somatic
complaints) with recurrent regional pain consultation and self-
reported CWP, although this was more marked for consultation
measures of poor health in recurrent regional pain consulters and
for survey measures in those with self-reported CWP.
The primary care coding prevalence of fibromyalgia was
considerably lower than that predicted by community prevalence,
even accounting for a proportion of patients not consulting for
their symptoms. This is consistent with findings from 2 large
database studies.10,16 The combined 5-year prevalence of
recurrent regional pain consultation (“unrecognized” CWP) and
nonspecific pain complaints (“recognized” CWP), after excluding
specific generalized musculoskeletal diagnoses, was slightly
higher, at 13%, than general population point prevalence
estimates for CWP (10%).26 Combined with our findings from
Phase 2, this indicates that prevalence of widespread pain based
on consultation data may give similar prevalence estimates to
general population surveys based on strict CWP criteria, but will
not represent an identical group of people.
Recurrent regional pain consultation was more common in
females and increased with age, consistent with that reported for
CWP in the general population.26 It was associated with more
somatic symptoms, self-reported sleep problems and cognitive
impairment, and poorer self-reported physical and mental health
than observed in those consulting only for single-region problems.
Theseare all features consistentwithCWP.Somatic symptomsare
a part of the ACR-2010 definition for fibromyalgia, including fatigue
and waking unrefreshed.41 Other research has also shown
fibromyalgia and CWP to be associated with poor self-reported
mental and physical health.38,40 Recurrent regional pain consulters
were more likely to be frequent attenders, which is consistent with
research linking frequent attendance to both CWP13,21,27 and
medically unexplained syndromes.31,36 However, it may also be
a feature of the self-fulfilling nature of a definition that requires
repeated consultation, although we excluded musculoskeletal
conditions from our definition of frequent attendance.
Half of recurrent regional pain consulters did not self-report
widespread pain at either of the 2 survey points 3 years apart,
and only a third of those self-reporting persistent widespread
pain fulfilled the recurrent regional pain consulter definition.
Fulfilling recurrent regional pain consultation criteria was
associated with worse consultation-based health than self-
reporting persistent widespread pain, whereas persistent
widespread pain was associated with worse self-reported
health than recurrent regional pain consultation. Rather than
identifying all CWP patients who consult their GP, the recurrent
regional pain consultation definition identifies a specific group of
patients who may be unrecognized as having a generalized
condition, and therefore, through their consultation behavior,
are expressing a need that may remain unmet. This group is
consequently an important one because identifying them and
managing them appropriately has the potential to improve their
health and reduce consultation demands.
The recurrent regional pain consulter definition represents
a promising phenotype for EHR studies as it identifies patients
with nonlocal pain who have higher rates of disability and health
care use. However, given the disparity between self-reported
CWP and recurrent regional pain consultation, it is possible we
should consider other approaches to developing a consultation-
based definition of CWP, based on 2 observations. First, only 7%
of all those with persistent widespread pain had no record of
a musculoskeletal consultation during the study period; muscu-
loskeletal consultation thereby represents a reasonable sampling
frame for identifying and managing CWP in the population.
Second, single-site musculoskeletal consultation seems to
represent a low-severity group (by both consultation and self-
reportmeasures). Given this, it may be that systematically seeking
information about other pain sites could be a simple way to
ensure that GPs consider the extent of pain in their care and
management of patients and may be useful for future de-
velopment of EHR-based pain phenotypes. The highest severity
group—thosewith combined recurrent regional pain consultation
Table 3
Phase 2: overlap of consultation-based pain and self-reported pain status (n, row%, [column %]).












No self-reported pain 532 44.0% 331 27.4% 288 23.8% 59 4.9% 1210
(31.8%) (16.7%) (10.1%) (3.3%) (14.6%)
Pain that is not widespread 873 20.8% 1116 26.6% 1429 34.0% 785 18.7% 4203
(52.1%) (56.4%) (50.2%) (44.0%) (50.7%)
Non-persistent widespread pain (baseline or 3 years) 192 11.4% 338 20.1% 656 39.0% 497 29.5% 1683
(11.5%) (17.1%) (23.0%) (27.8%) (20.3%)
Persistent widespread pain (baseline and 3 years) 78 6.6% 194 16.3% 473 39.7% 445 37.4% 1190
(4.7%) (9.8%) (16.6%) (24.9%) (14.4%)
Total 1675 20.2% 1979 23.9% 2846 34.3% 1786 21.6% 8286
Row %s are shown in italics next to the n that they are associated with.
Column %s are shown in brackets below the n that they are associated with.
NB: Column %s represent positive predictive values of consultation-based definitions for self-reported pain.
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Table 4
Phase 2: results of logistic/linear regression analyses to compare consultation-based and self-reported health characteristics
between recurrent regional pain consultation and self-reported persistent widespread pain status.
Number (%)/mean (SD) Effect estimate (95% CI) Type of effect estimate
Consultation-based
Frequent attendance*
Recurrent regional pain consulter and
persistent widespread pain
121 (27) 7.07 (5.21 to 9.58) Odds ratio†
Recurrent regional pain consulter not
persistent widespread pain
284 (21) 4.99 (3.87 to 6.43) Odds ratio†
Persistent widespread pain not recurrent
regional pain consulter
88 (12) 2.55 (1.86 to 3.48) Odds ratio†
Single-region consulters not persistent
self-reported widespread pain
(reference)
87 (5) Reference Odds ratio†
One or more somatic symptoms‡
Recurrent regional pain consulter and
persistent widespread pain
396 (89) 4.73 (3.45 to 6.47) Odds ratio†
Recurrent regional pain consulter not
persistent widespread pain
1171 (87) 4.03 (3.34 to 4.86) Odds ratio†
Persistent widespread pain not recurrent
regional pain consulter
567 (76) 1.89 (1.55 to 2.30) Odds ratio†
Single-region consulters not persistent
self-reported widespread pain
(reference)
1111 (62) Reference Odds ratio†
Self-reported
Reporting of sleep problems on most nights§
Recurrent regional pain consulter and
persistent widespread pain
269 (60) 3.07 (2.47 to 3.81) Odds ratio†
Recurrent regional pain consulter not
persistent widespread pain
549 (41) 1.42 (1.22 to 1.64) Odds ratio†
Persistent widespread pain not recurrent
regional pain consulter
441 (59) 2.97 (2.48 to 3.54) Odds ratio†
Single-region consulters not persistent
self-reported widespread pain
(reference)
573 (32) Reference Odds ratio†
SF-12 physical component summary‖
Recurrent regional pain consulter and
persistent widespread pain
30.3 (9.5) 215.53 (216.72 to 214.34) Mean difference{
Recurrent regional pain consulter not
persistent widespread pain
39.0 (11.7) 26.42 (27.23 to 25.61) Mean difference{
Persistent widespread pain not recurrent
regional pain consulter
32.6 (11.1) 213.18 (214.15 to 212.21) Mean difference{
Single-region consulters not persistent
self-reported widespread pain
(reference)
45.7 (11.1) Reference Mean difference{
HADS anxiety score#
Recurrent regional pain consulter and
persistent widespread pain
8.8 (4.2) 2.72 (2.30 to 3.15) Mean difference{
Recurrent regional pain consulter not
persistent widespread pain
7.0 (4.0) 1.07 (0.78 to 1.36) Mean difference{
Persistent widespread pain not recurrent
regional pain consulter
8.4 (4.4) 2.34 (1.99 to 2.69) Mean difference{
Single-region consulters not persistent
self-reported widespread pain
(reference)
5.9 (3.9) reference Mean difference{
HADS depression score#
Recurrent regional pain consulter and
persistent widespread pain
6.6 (3.6) 2.95 (2.60 to 3.31) Mean difference{
Recurrent regional pain consulter not
persistent widespread pain
4.7 (3.3) 1.00 (0.75 to 1.24) Mean difference{
Persistent widespread pain not recurrent
regional pain consulter
6.3 (4.0) 2.65 (2.36 to 2.94) Mean difference{
Single-region consulters not persistent
self-reported widespread pain
(reference)
3.7 (3.1) reference Mean difference{
(continued on next page)
116 K.E. Mansfield et al.·158 (2017) 110–119 PAIN®
and self-reported CWP—suggests that both sources of
information could be useful for care and prevention.
We performed this study in 2 large samples of patients, using
high-quality primary care data and validated self-report instru-
ments. The studies were limited to one area of the United
Kingdom (North Staffordshire) and the use of an older age group
in Phase 2. However, sensitivity analyses using the CiPCA data
(not presented) demonstrated minimal differences in the number
of recorded somatic symptoms and musculoskeletal consulta-
tions between recurrent regional pain consulters from all age
groups and the subgroup aged $45 years. Less than a third of
the eligible population (ie, those invited to take part in the baseline
study) was included in analyses in Phase 2, and we cannot
exclude participation bias. However, we demonstrated that
differences between the study sample and nonresponders and
partial responders were small.
Not all patients with a problem will consult their GP for it;
consequently, consultation prevalence will be lower than
community population prevalence estimates. For chronic con-
ditions, a diagnostic label for a repeatedly consulted complaint
may only be coded at diagnosis.18 The use of a 5-year period to
define recurrent regional pain consultation would mean it is less
likely we have missed a relevant diagnosis in the Phase 1 study,
but it is possible some patients were recorded with fibromyalgia
or other diagnosis outside of this period.
We have attempted to define a relatively newly identified
phenotype, a group of recurrent pain consulters in primary care,
with a prevailing symptom of chronic musculoskeletal pain, who
are potentially unrecognized by their GPs as having a generalized
condition associated with somatic symptoms. We therefore had
no reference standard against which to compare the recurrent
regional pain consulters identified by our algorithm. However, the
recurrent regional pain consultation phenotype is closely related
to fibromyalgia/CWP, and these conditions have been studied
extensively using the ACR-1990 definition. We were able to
demonstrate that recurrent regional pain consulters share many
characteristics with CWP.
We included 4482 regional musculoskeletal Read codes in the
definition of recurrent regional pain consultation based on
previous consensus work. However, the codes may not always
indicate musculoskeletal pain (eg, unstable ankle), and the list
includes codes for conditions that may not be appropriate for use
in CWP, such as structural derangements (eg, meniscal tears),
infections, and inflammatory arthropathies. There may be other
codes with the potential to represent musculoskeletal problems.
Evidence of widespread pain and somatic symptomsmay also be
“hidden” in the free text of the consultation.
Our study suggests that recurrent regional pain consulters
represent a heterogeneous subgroup of frequent consulters, with
chronic musculoskeletal problems as the prevailing symptom of
their polysymptomatic distress, who may not be recognized as
having a more generalized pain condition associated with somatic
symptoms. They include those less severely affected, who do not
necessarily fit established and strict CWP criteria, and therefore
reflect an overlapping rather than identical group of persons. They
nonetheless still exist on the spectrum of polysymptomatic distress
characteristic of CWP and fibromyalgia.
The recurrent regional pain consulter algorithm highlights the
existence of a substantial group of patients with potentially unmet
needs. Treatment focused on regional pain syndromes alonemay
be suboptimal if the added burden of pain elsewhere in the
body—and the additional characteristics associated with it (such
as pain severity and propensity for long-term persistence)—is not
identified and taken into account in explanation, advice, and care
given to the patient.4,25
There is some underrecognition of CWP in primary care, implying
a need for specific training for GPs. If some patients are not
recognized as having generalized pain conditions with associated
somatic symptoms, they may be inappropriately managed (as
multiple episodes of regional pain). Ineffective management may
lead to poor patient outcomes and contribute unnecessarily to
primary care workload (continued consultation for unresolved
symptoms). Screening for multisite pain in patients presenting with
single-sitemusculoskeletal complaintsmaybe a simpleway forGPs
to consider the extent of pain in their management. Future research
should explore this clinically important group of chronic consulters.
Although there seem to be effective treatments for patients with
widespread pain, we do not yet understand how best to help those
recurrently consulting for regional musculoskeletal pain. Recurrent
consultation for local musculoskeletal pain offers a means of
identifying a clinically relevant group of high users of primary care.
Further research to investigate changes in their health over time, the
Table 4 (continued)
Number (%)/mean (SD) Effect estimate (95% CI) Type of effect estimate
Cognitive impairment score**
Recurrent regional pain consulter and
persistent widespread pain
22.6 (26.1) 12.79 (10.45 to 15.12) Mean difference{
Recurrent regional pain consulter not
persistent widespread pain
14.0 (21.2) 3.99 (2.41 to 5.57) Mean difference{
Persistent widespread pain not recurrent
regional pain consulter
21.2 (25.6) 11.46 (9.54 to 13.38) Mean difference{
Single-region consulters not persistent
self-reported widespread pain
(reference)
9.9 (19.0) reference Mean difference{
Recurrent regional pain consulter and persistent widespread pain: n 5 445.
Recurrent regional pain consulter not persistent widespread pain, n 5 1341.
Persistent widespread pain not recurrent regional pain consulter, n 5 745.
Single-region consulters not persistent widespread pain, n 5 1785.
* Frequent attendance model x2 (5) 5 334.96, P , 0.001.
† Odds ratio calculated using logistic regression controlling for age and sex, with single-region consulters without persistent self-reported widespread pain as the reference group.
‡ One or more somatic symptoms model x2 (5) 5 373.65, P , 0.001.
§ Reporting of sleep problems on most nights x2 (5) 5 246.72, P , 0.001.
‖ Twelve-item short-form health survey–physical component summary39: high score 5 best health.
{ Mean difference (recurrent regional pain consulter/persistent widespread pain group minus single-region consulter not persistent widespread pain group) calculated using linear regression controlling for age and sex.
# Hospital Anxiety and Depression Scale43: high score 5 worst health.
** Sickness Impact Profile—Alertness subscale5: high score 5 worst health.
CI, confidence interval; SD, standard deviation.
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financial cost of their management, and possible interventions
would offer insights into long-term health outcomes, current
economic burden, and management of individuals who consult
with nonlocal pain complaints.
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